ANDA 77868, held by Watson Labs. Topiramate.
As of Nov 15, 2026, ANDA 77868 (Topiramate), held by Watson Labs, was first approved by FDA on Apr 15, 2009, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 15, 2009 | Original application | Approved |
| Topiramate15MG · capsule;oral | Topiramate | Discontinued |
| Topiramate25MG · capsule;oral | Topiramate | Discontinued |
| Oct 25, 2014 | Supplement 8Labeling | Approved | None posted |
| Oct 25, 2014 | Supplement 11Labeling · Standard review | Approved | None posted |
| Aug 18, 2011 | Supplement 7Labeling | Approved | None posted |
| Dec 23, 2010 | Supplement 3Labeling | Approved | None posted |
| Jan 28, 2010 | Supplement 1Labeling | Approved | None posted |
| Apr 15, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters